Terug
46
Ook genoteerd als
SNYNF
OTC
Dagbereik
€ 44,50
€ 45,25
52-Weeksbereik
€ 43,32
€ 56,93
Volume
3.063.026
50D / 200D Gem.
€ 46,55
/
€ 48,31
Vorige Slotkoers
€ 44,60
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 14,0 | 0,4 |
| P/B | 1,5 | 2,9 |
| ROE % | 10,5 | 3,8 |
| Net Margin % | 16,7 | 3,9 |
| Rev Growth 5Y % | 4,5 | 10,0 |
| D/E | 0,3 | 0,2 |
Koersdoel Analisten
Hold
€ 57,02
+27.4%
Low: € 48,07
High: € 64,00
Forward K/W
10,6
Forward WPA
€ 4,23
WPA Groei (sch.)
+0,0%
Omzet Sch.
48 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,02
€ 5,74 – € 6,53
|
58 B | 2 |
| FY2029 |
€ 5,47
€ 5,21 – € 5,93
|
56 B | 4 |
| FY2028 |
€ 4,94
€ 4,71 – € 5,36
|
53 B | 3 |
Belangrijkste Punten
Revenue grew 4,50% annually over 5 years — modest growth
Earnings grew 40,52% over the past year
ROE of 10,50% — decent returns on equity
Net margin of 16,72% shows strong profitability
Debt/Equity of 0,31 — conservative balance sheet
Generating 8,89B in free cash flow
Groei
Revenue Growth (5Y)
4,50%
Revenue (1Y)5,49%
Earnings (1Y)40,52%
FCF Growth (3Y)1,45%
Kwaliteit
Return on Equity
10,50%
ROIC5,11%
Net Margin16,72%
Op. Margin13,58%
Veiligheid
Debt / Equity
0,31
Current Ratio1,09
Interest Coverage11,73
Waardering
P/E Ratio
13,96
P/B Ratio1,53
EV/EBITDA19,41
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,49% | Revenue Growth (3Y) | 5,95% |
| Earnings Growth (1Y) | 40,52% | Earnings Growth (3Y) | 20,29% |
| Revenue Growth (5Y) | 4,50% | Earnings Growth (5Y) | 5,85% |
| Profitability | |||
| Revenue (TTM) | 46,72B | Net Income (TTM) | 7,81B |
| ROE | 10,50% | ROA | 6,16% |
| Gross Margin | 72,34% | Operating Margin | 13,58% |
| Net Margin | 16,72% | Free Cash Flow (TTM) | 8,89B |
| ROIC | 5,11% | FCF Growth (3Y) | 1,45% |
| Safety | |||
| Debt / Equity | 0,31 | Current Ratio | 1,09 |
| Interest Coverage | 11,73 | Dividend Yield | 0,05% |
| Valuation | |||
| P/E Ratio | 13,96 | P/B Ratio | 1,53 |
| P/S Ratio | 2,33 | PEG Ratio | -1,66 |
| EV/EBITDA | 19,41 | Dividend Yield | 0,05% |
| Market Cap | 109,03B | Enterprise Value | 123,16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 46,72B | 44,29B | 41,62B | 40,56B | 39,18B |
| Net Income | 7,81B | 5,56B | 5,40B | 8,37B | 6,22B |
| EPS (Diluted) | 2,03 | 2,19 | 2,15 | 3,18 | 2,49 |
| Gross Profit | 33,79B | 31,08B | 28,99B | 28,68B | 26,92B |
| Operating Income | 6,34B | 7,25B | 6,96B | 10,16B | 8,13B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 126,81B | 132,80B | 126,46B | 126,72B | 120,24B |
| Total Liabilities | 55,10B | 54,94B | 52,11B | 51,57B | 51,21B |
| Shareholders' Equity | 71,38B | 77,51B | 74,04B | 74,78B | 68,68B |
| Total Debt | 21,79B | 17,91B | 18,70B | 21,21B | 22,41B |
| Cash & Equivalents | 7,66B | 7,44B | 8,71B | 12,74B | 10,10B |
| Current Assets | 30,95B | 42,59B | 30,66B | 34,03B | 30,56B |
| Current Liabilities | 28,35B | 29,16B | 24,19B | 23,96B | 21,30B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#501 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026